pharma Archives - Page 3 of 5 - Health Issues India

Controversy continues over HPV vaccine and cervical cancer

Leave a Comment / Access to Healthcare, Featured, Government policy, Medicine and Research, National, News, Noncommunicable diseases, Opinion, Social issues / By Editor, Health Issues

Controversy continues over the human papillomavirus (HPV) vaccine used to prevent cervical cancer in women. Reports suggest India’s health ministry will not include it under the country’s universal immunisation programme (UIP). Estimates suggest 1 in 53 women in India will develop cervical cancer in their lifetime. It is believed 423.2 million women aged fifteen and …

Controversy continues over HPV vaccine and cervical cancer Read More »

India to become the pharmacy of the Philippines?

Leave a Comment / Access to Healthcare, Featured, Government policy, International, Medicine and Research, News, Science and Technology / By Editor, Health Issues

President of the Philippines Rodrigo Duterte is keen to capitalise on India’s generic medicines industry. Biateral talks occurred last month between Duterte and Prime Minister Narendra Modi at the Philippine International Convention Centre in Pasay City. During the talks, Duterte noted the potential of India’s pharmaceutical industry to expand into the Philippines. The proposal came …

India to become the pharmacy of the Philippines? Read More »

Chhattisgarh sterilisation camp deaths: Three years on

Leave a Comment / Access to Healthcare, Featured, Government policy, National, Opinion, Social issues / By Editor, Health Issues

On November 8, 2014, 140 women underwent surgery in two state-run sterilisation camps in Chhattisgarh. Five days later, thirteen of them had died. The tragedy grabbed global headlines. Three years later, it remains an open wound in India. At the time, it seemed as if there was one, easy-to-identify cause that could be addressed through …

Chhattisgarh sterilisation camp deaths: Three years on Read More »

A climate of pollution in Hyderabad: Pharma to blame?

1 Comment / Featured, Government policy, National, News, Opinion / By Editor, Health Issues

Hyderabad’s pharma boom is having a devastating effect on the environment. Five major pharmaceutical companies have been charged with making water and the atmosphere toxic. The Telangana State Pollution Control Board (TSPCB) warn that the state capital’s emerging pharmaceutical industry faces ‘stringent action’ because of pollution from pharma plants. This follows the death of 230,000 …

A climate of pollution in Hyderabad: Pharma to blame? Read More »

Marketing to doctors: Pharma faces crackdown

Leave a Comment / Access to Healthcare, Featured, Government policy, National, News, Social issues / By Editor, Health Issues

Drugmakers could face new marketing restrictions in India, should new rules come into force. A set of marketing rules would limit the amount drugmakers can spend on gifts and trips offered to doctors and pharmacists to Rs 1,000 (US$15) per gift. The proposals propose stringent penalties. Violating the rules would result in a marketing suspension …

Marketing to doctors: Pharma faces crackdown Read More »

India’s Goods and Services Tax (GST): What does it mean for pharma?

Leave a Comment / Access to Healthcare, Featured, Government policy, Medicine and Research, National, News / By Editor, Health Issues

India’s long-awaited and divisive Goods and Services Tax (GST) will soon take effect. What effect will it have on healthcare? The GST has effectively more than thirty years in the making. A large-scale stab at tax reform, it seeks to impose a levy on all goods and services across India at the national level. The …

India’s Goods and Services Tax (GST): What does it mean for pharma? Read More »

India is fighting at the WHO to make medicines cheaper, but drug quality is the real problem

Leave a Comment / Access to Healthcare, Featured, Government policy, International, Medicine and Research, News, Opinion / By Editor, Health Issues

This has been reproduced, with permission, from The News Minute. Full credit goes to the author Ramanathan S. (@madrassi). The original article can be accessed here Not very far from the Serpentine Bar at the Palace of Nations in Geneva, the United Nations HQ, where both lobbyists of the private sector and non-state actors are competing …

India is fighting at the WHO to make medicines cheaper, but drug quality is the real problem Read More »

Bucking the trend: Is India’s drug market back on the up?

Leave a Comment / Access to Healthcare, Featured, Government policy, International, Medicine and Research, National, News / By Editor, Health Issues

“Bucking the trend” India’s drug market is starting to show signs of improvement after a rough few months, with everything from demonetisation to Donald Trump taking its toll. However, the future remains very much unclear. Demonetisation The Indian pharmaceutical market (IPM) is “bucking the trend of a sequential decline” according to MoneyControl, growing 9.6 percent …

Bucking the trend: Is India’s drug market back on the up? Read More »

Gates Foundation and India: ties cut or fake news at play?

Leave a Comment / Featured, Government policy, National, News / By Editor, Health Issues

Ties between one of India’s largest immunization programs and the Gates Foundation have been cut, media reports suggest. However, the Health Ministry dismisses such claims as “misleading.” “Shut the gate” on Gates The Economic Times reports that the Modi government has “shut the gate” on the Bill & Melinda Gates Foundation as far as the …

Gates Foundation and India: ties cut or fake news at play? Read More »

Health budget: Making progress or playing it safe?

Leave a Comment / Access to Healthcare, Featured, Government policy, Medicine and Research, National, News, Opinion, Social issues / By Editor, Health Issues

The Modi government’s Union Budget for the fiscal year 2017-18 was presented by Finance Minister Arun Jaitley on February 1. Jaitley announced a number of steps to address the plentiful problems facing India’s healthcare system. However, critics said that there were only paltry increases in funding following a year of severe cuts – a “nominal” …

Health budget: Making progress or playing it safe? Read More »

Offer An Article

Pandemic Latest News

pharma